ShareTweetShareAbattis Bioceuticals Corp. (CSE: ATT) appears to have avoided delisting from the Canadian Securities Exchange, if only narrowly. The equity … Continue reading Abattis Bioceuticals Narrowly Avoids Delisting from Canadian Securities Exchange